Objective: To examine whether hyperthermia aggravates cerebral injury in acute ischemia by an excitotoxic mechanism, we studied the relationship between body temperature on admission and CSF concentrations of neuroexcitatory amino acids in 128 patients with acute ischemic stroke of less than 24 h duration. Methods: Stroke worsening was defined as the percent change between the Canadian Stroke Scale (CSS) at 48 h and the CSS on admission. Infarct volume was measured on days 4–7 on cranial computed tomography. Excitatory amino acids were analyzed using HPLC. Results: Glutamate concentration [median (min.-max.)] was 11 (2–19) µmol/l in hyperthermic patients (body temperature >37.5°C) and 5 (2–22) µmol/l in normothermic patients (p < 0.0001). Glycine concentration in hyperthermic and normothermic patients was 16 (3–21) µmol/l and 9 (3–50) µmol/l, respectively (p < 0.0001). Glutamate was significantly higher in patients with hyperthermia only during the first 12 h after the onset of symptoms. The CSF concentrations of glutamate (r = 0.52; p < 0.0001) and glycine (r = 0.62; p < 0.0001) correlated with body temperature. Body temperature was significantly related to stroke worsening and infarct size, but this effect was dependent on the glutamate effect. Conclusion: Glutamate and glycine release during the acute phase of cerebral ischemia could be responsible for the increased brain damage in hyperthermia.

Keywords:
Cerebral ischemia, Excitatory amino acids, Glutamate, Glycine, Hyperthermia
1.
Hindfelt B: The prognostic significance of subfebrility and fever in ischemic cerebral infarction. Acta Neurol Scand 1976;53:72–79.
2.
Terent A, Anderson B: The prognosis for patients with cerebrovascular stroke and transient ischemic attacks. Ups J Med Sci 1981;86:63–74.
3.
Castillo J, Martínez F, Leira R, Prieto JM, Lema M, Noya M: Mortality and morbidity of acute cerebral infarction related to temperature and basal analytic parameters. Cerebrovasc Dis 1994;4:66–71.
4.
Azzimondi G, Bassein L, Nomino F, Fiorani L, Vignatelli L, Re G, D’Alessandro R: Fever in acute stroke worsens prognosis: A prospective study. Stroke 1995;26:2040–2043.
5.
Reith J, Jorgensen HS, Pedersen PM, Nakayama H, Raaschon HO, Jeppesen LL, Olsen TS: Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality and outcome. Lancet 1996;347:422–425.
6.
Dávalos A, Castillo J, Pumar JM, Noya M: Body temperature and fibrinogen are related to early neurological deterioration in acute ischemic stroke. Cerebrovasc Dis 1997;7:64–69.
7.
Busto R, Dietrich WD, Globus MY-T, Valdés I, Scheinberg P, Ginsberg MD: Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 1987;7:729–738.
8.
Minamisawa H, Smith M-L, Siesjö BK: The effect of mild hyperthermia and hypothermia on brain damage following 5, 10 and 15 minutes of forebrain ischemia. Ann Neurol 1990;28:26–33.
9.
Ginsberg MD, Sternau LL, Globus MY-T, Dietrich WD, Busto R: Therapeutic modulation of brain temperature: Relevance to ischemic brain injury. Cerebrovasc Brain Metab Rev 1992;4:189–225.
10.
Nemoto EM, Frankel HM: Cerebral oxygenation and metabolism during progressive hyperthermia. Am J Physiol 1970;219:1784–1788.
11.
Lin B, Busto R, Globus MY-T, Martínez E, Ginsberg MD: Brain temperature modulations during global ischemia fail to influence extracellular lactate levels in rats. Stroke 1995;26:1634–1638.
12.
Baena RC, Busto R, Dietrich WD, Globus MY-T, Ginsberg MD: Hyperthermia delayed by 24 hours aggravates neuronal damage in rat hippocampus following global ischemia. Neurology 1997;48:768–773.
13.
Sternau LL, Globus MY-T, Martínez E, Dietrich WD, Busto R, Ginsberg MD: Ischemia-induced neurotransmitter release: Effects of mild intraischemic hyperthermia; in Globus MY-T, Dietrich WD (eds): The Role of Neurotransmitters in Brain Injury. New York, Plenum Press, 1992, pp 33–38.
14.
Baker CJ, Fiore AJ, Frazzini VI, Choudhri TF, Zubay GP, Solomon RA: Intraischemic hypothermia decreases the release of glutamate in the cores of permanent focal cerebral infarcts. Neurosurgery 1995;36:994–1002.
15.
Nakashima K, Todd MM: Effects of hypothermia on the rate of excitatory amino acid release after ischemic depolarization. Stroke 1996;27:913–918.
16.
Butcher SP, Bullock R, Graham DI, McCulloch J: Correlation between amino acid release and neuropathologic outcome in rat brain following middle cerebral artery occlusion. Stroke 1990;21:1727–1733.
17.
Takagi K, Ginsberg MD, Globus MY-T, Dietrich WD, Martínez E, Kraydieh S, Busto R: Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: Correlation with histopathology. J Cereb Blood Flow Metab 1993;13:575–585.
18.
Kanthan R, Shuaib A, Griebel R, Miyashita H: Intracerebral human microdialysis: In vivo study of an acute focal ischemic model of the human brain. Stroke 1995;26:870–873.
19.
Bullock R, Zauner A, Woodward J, Young HF: Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 1995;26:2187–2189.
20.
Castillo J, Dávalos A, Naveiro J, Noya M: Neuroexcitatory amino acids and their relationship to infarct size and neurological deficit in ischemic stroke. Stroke 1996;27:1060–1065.
21.
Castillo J, Dávalos A, Noya M: Progression of ischaemic stroke and excitatory amino acids. Lancet 1997;349:79–83.
22.
Côté R, Hachinski VC, Shurvell BL, Norris JW, Wolfson C: The Canadian neurological scale: A preliminary study in acute stroke. Stroke 1986;17:731–737.
23.
Spackman DH, Stein WH, Moore S: Automatic recording apparatus for use in the chromatography of amino acids. Anal Chem 1958;30:1190–1206.
24.
Turnell DC, Cooper JDH: Rapid assay for amino acids in serum or urine by pre-column derivation and reversed-phase liquid chromatography. Clin Chem 1982;28:527–531.
25.
Dávalos A, Cendra E, Teruel J, Martínez M, Genís D: Deteriorating ischemic stroke: Risk factors and prognosis. Neurology 1990;40:1865–1869.
26.
Oppenheimer S, Hachinski V: Complications of acute stroke. Lancet 1992;339:721–724.
27.
Folbergrove J, Memezawa H, Smith ML, Siesjö BK: Focal and perifocal changes in tissue energy state during middle cerebral artery occlusion in normo- and hyperglycemic rats. J Cereb Blood Flow Metab 1992;12:25–33.
28.
Lo EH, Steinberg GK: Effects of hypothermia on evoked potentials, magnetic resonance imaging, and blood flow in focal ischemia in rabbits. Stroke 1992;23:889–893.
29.
Dietrich WD, Alonso O, Busto R: Moderate hyperglycemia worsens acute blood-brain barrier injury after forebrain ischemia in rats. Stroke 1993;24:111–116.
30.
Choi DW, Rothman SM: The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990;13:171–182.
31.
Uchiyama-Tsuyuki Y, Araki H, Yae T, Otomo S: Changes in the extracellular concentrations of amino acids in the rat striatum during transient focal cerebral ischemia. J Neurochem 1994;62:1074–1078.
32.
Matsumoto K, Graf R, Rosner G, Taguchi J, Heiss WD: Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J Cereb Blood Flow Metab 1993;13:586–594.
33.
Shimada N, Graf R, Rosner G, Heiss WD: Ischemia-induced accumulation of extracellular amino acids in cerebral cortex, white matter, and cerebrospinal fluid. J Neurochem 1993;60:66–71.
34.
Dávalos A, Castillo J, Serena J, Noya M: Duration of glutamate release after acute ischemic stroke. Stroke 1997;28:708–710.
35.
Dávalos A, Castillo J: Potential mechanisms of worsening. Cerebrovasc Dis 1997;7(suppl 5):19–24.
36.
Wahl F, Obrenovitch TP, Hardy AM, Plotkine M, Boulu RG, Symon L: Glutamate effluxes from the rat striatum during focal cerebral ischemia: Time course and calcium dependency; in Krieglstein J, Oberpichler-Schwenk H (eds): Pharmacology of Cerebral Ischemia 1994. Stuttgart, Medpharm Scientific Publishers, 1994, pp 157–164.
37.
Greenamyre JT, Porter HP: Anatomy and physiology of glutamate in CNS. Neurology 1994;44(suppl 8):S7–S13.
38.
Castillo J, Dávalos A, Lema M, Serena J, Noya M: Glutamate is a marker for cerebral ischemia in cortical but not deep infarcts. Cerebrovasc Dis 1997;7:245–250.
39.
Fern R, Waxman SG, Ranson SG: Modulation of anoxic injury in CNS white matter by adenosine, and interaction between adenosine and GABA. J Neurophysiol 1994;72:2609–2616.
40.
Waxman SG: Different strokes in different folks: Unique molecular signatures of cortical and deep brain infarcts. Cerebrovasc Dis 1997;7:243–244.
41.
Stys PK, Waxman SG, Ranson BR: Effects of temperature on evoked electrical activity and anoxic injury in CNS white matter. J Cereb Blood Flow Metab 1992;12:977–986.
42.
Kemp JA, Leeson PD: The glycine site of the NMDA receptor – Five years on. Trends Pharmacol Sci 1993;14:20–25.
43.
Ginsberg MD, Busto R: Combating hyperthermia in acute stroke: A significant clinical concern. Stroke 1998;29:529–534.
44.
Siesjö BK: Editorial comment. Neurosurgery 1995;36:1001.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.